Washington, DC – Lake City Medical Center was honored with an “A” Hospital Safety ScoreSM by The Leapfrog Group, an independent national nonprofit run by employers and other large purchasers of health benefits. The Hospital Safety Score assigns an A, B, C, D or F letter grade to local hospitals based on its safety in preventing errors, infections, injuries and medication mix-ups. The goal of the Hospital Safety Score is to reduce the more than 440,000 yearly deaths from hospital errors and injuries by publicly recognizing safety and exposing harm.
“Patient safety and well-being are our number one priority at Lake City Medical Center”, said Mark Robinson, CEO. “To receive an “A” in this recent fall survey shows our commitment to keeping patients safe and validates the great processes we have put in place at our hospital.”
Despite major strides over the past few years, hospital safety and quality still vary across the United States. A hospital may have the best surgeons and greatest technology in the world, but unless it is preventing infections, and eliminating medical and medication errors and injuries, it is not delivering on a very basic premise: ensuring the safety of you and your loved ones. The Hospital Safety Score empowers patients to make informed decisions about the safety of hospital care.
To see Lake City Medical Center’s scores as they compare nationally and locally, visit www.hospitalsafetyscore.org, the Hospital Safety ScoreSM website, which also provides information on how the public can protect themselves and loved ones during a hospital stay.
Calculated under the guidance of The Leapfrog Group’s eight-member Blue Ribbon Expert Panel, the Hospital Safety Score uses 28 measures of publicly available hospital safety data to produce a single score representing a hospital’s overall capacity to keep patients safe from infections, injuries and medical and medication errors. The panel includes: John Birkmeyer, MD (University of Michigan), Ashish Jha, MD, MPF (Harvard University), Arnold Milstein, MD, MPH (Stanford University), Peter Pronovost, MD, PhD (Johns Hopkins School of Medicine), Patrick Romano, MD, MPH (University of California, Davis), Sara Singer, PhD (Harvard University), Tim Vogus (Vanderbilt University) and Robert Wachter, MD (University of California, San Francisco).